Brett Goldsmith

A founding member of Nanomed and the company’s CTO, Dr. Goldsmith’s passion is taking nanoelectronic technology out of the theoretical realm to create practical and manufacturable products that better people’s lives. One of the few people in the world with the combined expertise in biology and nanotechnology needed to develop graphene as a viable bio-electronic device, Dr. Goldsmith was the lead researcher on landmark academic papers in Science and Nature Nanotechnology demonstrating the coupling of biochemical systems to carbon nanotubes, for which he won the Nottingham Prize from the Physics Electronics Conference. Following graduate school at UC Irvine, Dr. Goldsmith joined the University of Pennsylvania as an Intelligence Community Fellow and led a project developing nanoelectronic sensing of Lyme biomarkers as well as successfully integrated membrane proteins with nanoelectronic circuits. Leaving his post-doc position to start a nanotechnology group at the Navy’s San Diego laboratory, Dr. Goldsmith identified technological needs in the field and advanced nanotechnology solutions to those needs through partnership with programs including Living Foundries and IVN Dx. Prior to founding Nanomed, Dr. Goldsmith was the CTO of Nanosense in Mountain View where he developed and drove the first successful fabrication of a nanoelectronic sensing system in the chemical manufacturing industry in the form of commercial industrial gas sensors. Dr. Goldsmith brings proven experience in transforming academic learnings into viable commercial fabrications to his role as CTO of Nanomed.

Brett Goldsmith is the Chief Technology Officer at Cardea Bio, based in United States, North America. With a background in Information Technology, Brett Goldsmith has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.